Oncology Drug Prescribing: The Influences of Greed and Fear

被引：4
作者：
Ratain, Mark J. [1 ]
机构：
[1] Univ Chicago, 5841 S Maryland Ave,2115,MC 2115, Chicago, IL 60637 USA
来源：
JCO ONCOLOGY PRACTICE | 2022年 / 18卷 / 09期
关键词：
D O I：
10.1200/OP.22.00381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E1384 / E1387
页数：4
相关论文
共 12 条
[1]   Evaluating Open Payments [J].
Kanter, Genevieve P. ;
Loewenstein, George .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (05) :401-402
[2]   Oncology's "Hockey Stick" Moment for the Cost of Cancer Drugs-The Climate Is About to Change [J].
Polite, Blase N. ;
Ratain, Mark J. ;
Lichter, Allen S. .
JAMA ONCOLOGY, 2021, 7 (01) :25-26
[3]   Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial [J].
Ross, Eric L. ;
Hutton, David W. ;
Stein, Joshua D. ;
Bressler, Neil M. ;
Jampol, Lee M. ;
Glassman, Adam R. .
JAMA OPHTHALMOLOGY, 2016, 134 (08) :888-896
[4]   Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value [J].
Serritella, Anthony V. ;
Strohbehn, Garth W. ;
Goldstein, Daniel A. ;
Lichter, Allen S. ;
Ratain, Mark J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) :487-493
[5]   The Drug-Dosing Conundrum in Oncology - When Less Is More [J].
Shah, Mirat ;
Rahman, Atiqur ;
Theoret, Marc R. ;
Pazdur, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1445-1447
[6]   Open Payments Database: Anti-Vascular Endothelial Growth Factor Agent Payments to Ophthalmologists [J].
Singh, Nakul ;
Chang, Jonathan S. ;
Rachitskaya, Aleksandra V. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 173 :91-97
[7]   American Society of Clinical Oncology Policy for Relationships With Companies: Background and Rationale [J].
Spence, Rebecca ;
Michels, Dina ;
Moy, Beverly ;
Peppercorn, Jeffrey ;
Singer, Eric A. ;
Storm, Courtney ;
Helft, Paul .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) :2037-+
[8]   American Society of Clinical Oncology: Policy for Relationships With Companies [J].
Spence, Rebecca A. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) :796-798
[9]   Key Opinion Leaders [J].
Steensma, David P. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28) :3213-+
[10]   Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments [J].
Tannock, Ian F. ;
Ratain, Mark J. ;
Goldstein, Daniel A. ;
Lichter, Allen S. ;
Rosner, Gary L. ;
Saltz, Leonard B. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (09) :950-955
12